Biocon's Covid-19 Drug Itolizumab Approved for Emergency Use after Trial on Only 30 Patients
Itolizumab is an existing drug used to treat skin ailment Psoriasis. The Drug Controller General of India (DCGI) approved its restricted emergency use on Saturday.
from Top India News- News18.com https://ift.tt/32dxt1A
Labels: India, Top India News- News18.com
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home